Legend Biotech (纳斯达克代码: LEGN) 公布季度每股亏损为$(0.16)，优于分析师一致预期的$(0.33)，超出51.52%。与去年同期每股亏损$(0.24)相比，提高了33.33%。公司报告季度销售额为$1.8652亿，优于分析师一致预期的$1.7893亿，超出4.24%。与去年同期的销售额$7946万相比，提高了134.73%。

以上内容来自Benzinga Earnings专栏，原文如下：

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.33) by 51.52 percent. This is a 33.33 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $186.52 million which beat the analyst consensus estimate of $178.93 million by 4.24 percent. This is a 134.73 percent increase over sales of $79.46 million the same period last year.